Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 45 publications
0
6
0
Order By: Relevance
“…Recently, studies have shown that abnormal expression of GNPNAT1 is related to the carcinogenesis of lung cancer. Wang et al showed that the mRNA and protein expression levels of GNPNAT1 in lung cancer tissues were upregulated compared with normal tissues (22,23). The expression level of GNPNAT1 is related to the clinical stage and prognosis of lung cancer.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, studies have shown that abnormal expression of GNPNAT1 is related to the carcinogenesis of lung cancer. Wang et al showed that the mRNA and protein expression levels of GNPNAT1 in lung cancer tissues were upregulated compared with normal tissues (22,23). The expression level of GNPNAT1 is related to the clinical stage and prognosis of lung cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Wang et al. showed that the mRNA and protein expression levels of GNPNAT1 in lung cancer tissues were upregulated compared with normal tissues ( 22 , 23 ). The expression level of GNPNAT1 is related to the clinical stage and prognosis of lung cancer.…”
Section: Discussionmentioning
confidence: 99%
“…In primary lung adenocarcinoma and pancreatic cancer, VSIG2 was characterized as a member of the DNA methylation-related prognostic signature ( 60 , 61 ). High expression and methylation of VSIG2 correlated with poor survival in these cancer patients ( 58 , 60 , 61 ).…”
Section: Vsig2mentioning
confidence: 99%
“…VSIG2 expression has been found to be significantly upregulated in patients with nonmuscle invasive bladder cancer but downregulated in patients with muscle invasive bladder cancer; thus, it could serve as a biomarker of invasiveness in bladder cancers ( 59 ). In primary lung adenocarcinoma and pancreatic cancer, VSIG2 was characterized as a member of the DNA methylation-related prognostic signature ( 60 , 61 ). High expression and methylation of VSIG2 correlated with poor survival in these cancer patients ( 58 , 60 , 61 ).…”
Section: Vsig2mentioning
confidence: 99%
“…Due to the rise of bioinformatics technology in recent years, numerous studies have emerged to explore the prognostic markers of LUAD from different perspectives. There are relevant tumor marker studies involving the tumor microenvironment 2 , tumor metabolism 3 , cell cycle 4 , DNA methylation 5 , etc., but few studies have been related to hypoxia. This study was conducted to investigate the signature associated with the prognosis of lung adenocarcinoma using hypoxia-related genes as a breakthrough.…”
Section: Introductionmentioning
confidence: 99%